Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42,903 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Danlou tablets in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multicenter prospective cohort study.
Cai Y, Yang Q, Xi R, Yang F, Gu F, Zhao Y, Guo M, Dong G, Gao Z, Fu C, Wang P, Du J, Zhang D, Duan W, Li L, Shi D, Bai R. Cai Y, et al. Among authors: wang p. Front Cardiovasc Med. 2024 Sep 24;11:1420194. doi: 10.3389/fcvm.2024.1420194. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39380631 Free PMC article.
Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial.
Wang PL, Zhang L, Wang SL, Yang QN, Gao ZY, Du JP, Zhang DW, Fu CG, Gu F, Xu H, Li LZ, Wang CL, Shi DZ. Wang PL, et al. Chin J Integr Med. 2017 Oct;23(10):740-746. doi: 10.1007/s11655-016-2608-9. Epub 2016 Oct 24. Chin J Integr Med. 2017. PMID: 27778264 Clinical Trial.
The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): A nationwide Cohort Study.
Bai R, Yang Q, Xi R, Che Q, Zhao Y, Guo M, Dong G, Gao Z, Fu C, Wang P, Gu F, Du J, Zhang D, Duan W, Li L, Shi D. Bai R, et al. Among authors: wang p. Phytomedicine. 2023 Jan;109:154554. doi: 10.1016/j.phymed.2022.154554. Epub 2022 Nov 19. Phytomedicine. 2023. PMID: 36610159 Free article. Clinical Trial.
Effectiveness and Safety of Qishen Yiqi Dripping Pill in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: 3-Year Results from a Multicentre Cohort Study.
Bai RN, Gu F, Che QZ, Zhang X, Cai YJ, Xi RX, Zhao Y, Guo M, Dong GJ, Gao ZY, Fu CG, Wang PL, Du JP, Zhang DW, Duan WH, Li LZ, Yang QN, Shi DZ. Bai RN, et al. Chin J Integr Med. 2024 Oct;30(10):877-885. doi: 10.1007/s11655-024-3664-1. Epub 2024 Aug 21. Chin J Integr Med. 2024. PMID: 39172302
Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter Study.
Wang SL, Wang CL, Wang PL, Xu H, Liu HY, Du JP, Zhang DW, Gao ZY, Zhang L, Fu CG, Lü SZ, You SJ, Ge JB, Li TC, Wang X, Yang GL, Liu HX, Mao JY, Li RJ, Chen LD, Lu S, Shi DZ, Chen KJ. Wang SL, et al. Evid Based Complement Alternat Med. 2013;2013:741518. doi: 10.1155/2013/741518. Epub 2013 Jul 2. Evid Based Complement Alternat Med. 2013. PMID: 23935679 Free PMC article.
42,903 results
You have reached the last available page of results. Please see the User Guide for more information.